eIF4A inhibitors PatA and RocA stack the deck against translation.


Journal

Structure (London, England : 1993)
ISSN: 1878-4186
Titre abrégé: Structure
Pays: United States
ID NLM: 101087697

Informations de publication

Date de publication:
01 07 2021
Historique:
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 24 8 2021
Statut: ppublish

Résumé

In Cell Chemical Biology, Naineni et al. (2021) report the structure of a synthetic analog of the translation inhibitor pateamine A bound to initiation factor eIF4A and RNA. The drug stacks with RNA bases in the same pocket where unrelated rocaglate compounds bind, highlighting a druggable site for DEAD-box proteins.

Identifiants

pubmed: 34214439
pii: S0969-2126(21)00213-6
doi: 10.1016/j.str.2021.06.009
pii:
doi:

Substances chimiques

RNA 63231-63-0
Eukaryotic Initiation Factor-4A EC 2.7.7.-

Types de publication

Journal Article Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

638-639

Commentaires et corrections

Type : CommentOn

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The author declares no competing interests.

Auteurs

Nicholas T Ingolia (NT)

Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA. Electronic address: ingolia@berkeley.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH